4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001600620-26-000002
Chief Executive Officer gave up 113,169 shares (to pay taxes)
- Chief Executive Officer acquired 165,384 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greenleaf Peter Chief Executive Officer | 2026-01-02 | Grant or award | +165,384 | 1,954,329 | D: show line 1 in the form | ||
| Greenleaf Peter Chief Executive Officer | 2026-01-02 | Shares withheld for taxes | −113,169 | $15.95 | $1,805,046 | 1,845,037 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1767647395.xml…